Bought
Maintained
Sold
Other funds holding BIIB
Wafra's BIIB Position: Q2 2019 in Review
Wafra sold out of Biogen (BIIB) in Q2 2019, closing a stake of 44,430 shares — an estimated $10.5M sold.
Wafra first reported a position in BIIB in Q4 2013 and held it in 7 quarters. The position peaked at $24.7M in Q4 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.
- Wafra reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
- Wafra sold 44,430 Biogen shares in Q2 2019, an estimated $10.5M.
- Wafra first reported a position in Biogen in Q4 2013 and held it in 7 quarters.
- Wafra's Biogen position peaked at $24.7M in Q4 2018.
- 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.
Based on Wafra's 13F filing for Q2 2019, filed 14 Aug 2019.